FAM3D and head and neck squamous cell carcinoma: To identify the efficacy of FAM3D as biomarkers for predicting the treatment effectiveness in patients with HNSCC, the IC50 values for common anticancer drugs were explored with the pRRophetic algorithm in the FAM3D high- and low-expression groups.